Agenda
WEDNESDAY, SEPTEMBER 18, 2024
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Greg Simon, Former President, Biden Cancer Initiative. Topic: The Three Body Problem: What If There Were Nothing New?
9:40am // Corporate Presentation - Gan & Lee Pharmaceuticals USA (603087.SS)
9:55am // Corporate Presentation - InnoSIGN
10:10am // Corporate Presentation - Repair Biotechnologies
10:25am // Corporate Presentation - Cytogel Pharma
10:40am // Corporate Presentation - Pebble Life Science
10:55am // Corporate Presentation - Minerva Biotechnologies
11:10am // Corporate Presentation - Nanospun
11:25am // Corporate Presentation - Viropeutics
11:40am // Corporate Presentation - Duo Oncology
11:55am // Corporate Presentation - Creyon Bio
12:10pm // SPEAKER - Dennis Purcell, Founder, Aisling Capital | Frm Head of Healthcare Banking JP Morgan / H&Q. Topic: What’s Next for the Industry?
12:40pm // LUNCH BREAK
12:50pm // SPEAKERS - Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU) Technology Transfer Center | National Cancer Institute. Steven Ferguson, Special Advisor, NIH Office of Technology Transfer. Topic: Beyond SBIRs: Leveraging the NIH to Improve Pipelines and Bottom Lines
1:20pm // Corporate Presentation - Alphyn Biologics
1:35pm // Corporate Presentation - CureLab Oncology
1:50pm // Corporate Presentation - Synfini
2:05pm // Corporate Presentation - PartitionBio
2:20pm // Corporate Presentation - AvantGuard
2:35pm // Corporate Presentation - epiMedTech Global
2:50pm // Corporate Presentation - SciTech Development
3:05pm // Corporate Presentation - Tikva Allocell
3:20pm // Corporate Presentation - Scarlet Therapeutics
3:35pm // NETWORKING BREAK
3:50pm // Corporate Presentation - SFA Therapeutics
4:05pm // Corporate Presentation - UbiVac
4:20pm // Corporate Presentation - Aclipse Therapeutics
4:35pm // Corporate Presentation - NovAb
4:50pm // Corporate Presentation - Aanastra
5:05pm // SPEAKER - David Ribner, Partner, O'Melveny. Topic: Navigating U.S. Foreign Investment Regulations: CFIUS and Investment in Life Sciences
5:30pm // CLOSING REMARKS
5:40pm // RECEPTION
THURSDAY, SEPTEMBER 19, 2024
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // SPEAKERS - Dr. Michael Salgaller Supervisor, Technology Analysis and Marketing Unit (TAMU) Technology Transfer Center | National Cancer Institute. Steven Ferguson, Special Advisor, NIH Office of Technology Transfer. Topic: NIH as Your Technology Development and Commercialization Partner
9:40am // Corporate Presentation - Hemogenyx Pharmaceuticals (HEMO.L)
9:55am // Corporate Presentation - Jaguar Health (JAGX)
10:10am // Corporate Presentation - Aiviva BioPharma
10:25am // Corporate Presentation - BioAegis Therapeutics
10:40am // Corporate Presentation - Circular Genomics
10:55am // Corporate Presentation - Stingray Therapeutics
11:10am // Corporate Presentation - CraniUS
11:25am // NETWORKING BREAK
11:40am // Corporate Presentation - Leapfrog Bio
11:55am // Corporate Presentation - Intrommune Therapeutics
12:10pm // Corporate Presentation - Olfactive Biosolutions
12:25pm // SPEAKER - Nate Gallon. Partner, O'Melveny. Topic: M&A Earnouts: Bridging a Valuation Gap or a Bridge Too Far?
12:50pm // LUNCH BREAK
1:00pm // PANEL DISCUSSION: Moderator: Yaniv Sneor, Founder Mid Atlantic Bio Angels. Panel: Ario Arabi, Executive Director, Business Development & Licensing, Novartis; David Danar, Investment Committee Member, Catalytic Impact Foundation; Mike Baran, Partner at Pfizer Ventures and Executive Director, Worldwide Business Development
1:40pm // Corporate Presentation - Sanegenebio
1:55pm // Corporate Presentation - Reminded
2:10pm // Corporate Presentation - Lift BioSciences
2:25pm // Corporate Presentation - Angiex
2:40pm // Corporate Presentation - Brii Biosciences
2:55pm // SPEAKER - Geoff Kuziemko, Partner, O'Melveny. Topic: IP Licensing in Life Science Transactions
3:20pm // CLOSING REMARKS
3:30pm // RECEPTION